[Skin cancers in kidney transplant recipients]

Anna Bieryło1, Szymon Brzósko1, Elżbieta Laudańska1

  • 1I Klinika Nefrologii I Transplantologii Z Ośrodkiem Dializ Uniwersytetu Medycznego, Białystok, Polska.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|March 27, 2017
PubMed

Insights

Kidney transplant recipients on long-term immunosuppression face a higher risk of developing cancers, particularly skin cancers like squamous cell carcinoma and basal cell carcinoma. Immunosuppression also increases the incidence of rarer cancers in this patient group.

Area of Science:

  • Nephrology
  • Oncology
  • Immunology

Background:

  • Kidney transplantation is the optimal treatment for end-stage renal failure, significantly improving patient survival and quality of life.
  • Advancements in immunosuppressive therapies enhance graft survival but necessitate long-term immune system suppression.
  • An increasing number of kidney transplant recipients, including older individuals, are undergoing the procedure and require prolonged immunosuppression.

Purpose of the Study:

  • To highlight the increased risk of cancer development in kidney transplant recipients due to long-term immunosuppression.
  • To identify the types of malignancies most frequently observed in this patient population.
  • To underscore the association between immunosuppression and the incidence of both common and rare cancers post-transplant.

Main Methods:

  • Review of existing literature and clinical data on cancer incidence in kidney transplant recipients.
  • Analysis of the impact of immunosuppressive drug regimens on long-term outcomes.
  • Epidemiological assessment of common and rare malignancies in the post-transplant setting.

Main Results:

  • Skin cancers, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), are the most prevalent malignancies, accounting for 40-50% of cancers in renal transplant recipients.
  • Long-term immunosuppression is linked to a significant increase in the incidence of various cancers.
  • Transplant recipients exhibit a higher occurrence of rarer cancers such as melanoma, Merkel cell carcinoma, Kaposi's sarcoma, anogenital cancer, and sebaceous carcinoma compared to the general population.

Conclusions:

  • Kidney transplant recipients on long-term immunosuppression are at an elevated risk for developing various cancers, especially skin cancers.
  • The type and duration of immunosuppression play a crucial role in cancer development post-transplantation.
  • Increased surveillance for both common and rare malignancies is essential in the management of kidney transplant patients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
606
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
592
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
468
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.0K